Select the financial statements you wish to view below. The reports below may be viewed on either an annual or quarterly basis.
NYSECADE
- Income Statement
- Annual
All numbers in thousands USD
Period Ending | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 |
|---|---|---|---|---|
Total Revenue | 1,868,588 | 1,183,880 | 1,027,471 | 779,752 |
Cost of Revenue | -- | -- | -- | -- |
Gross Profit | -- | -- | -- | -- |
Operating Expenses | ||||
Research Development | 113,932 | -- | -- | -- |
Selling General and Administrative | 877,926 | 576,671 | 500,752 | 242,414 |
Non Recurring | -- | -- | -- | -- |
Others | (991,858) | (576,671) | (500,752) | (242,414) |
Total Operating Expenses | -- | -- | -- | -- |
Operating Income or Loss | -- | -- | -- | -- |
Income from Continuing Operations | ||||
Total Other Income/Expenses Net | -- | -- | -- | -- |
Earnings Before Interest And Taxes | -- | -- | -- | -- |
Interest Expense | 185,037 | 76,322 | 108,526 | 208,903 |
Income Before Tax | 599,375 | 246,928 | 287,545 | 262,301 |
Income Tax Expense | 136,138 | 51,766 | 59,494 | 60,343 |
Minority Interest | -- | -- | -- | -- |
Net Income From Continuing Ops | 463,237 | 195,162 | 228,051 | 201,958 |
Non-recurring Events | ||||
Discontinued Operations | -- | -- | -- | -- |
Extraordinary Items | -- | -- | -- | -- |
Effect Of Accounting Changes | -- | -- | -- | -- |
Other Items | 0 | 0 | 0 | 0 |
Net Income | 463,237 | 195,162 | 228,051 | 201,958 |
Preferred Stock And Other Adjustments | 9,488 | 9,488 | 9,488 | -- |
Net Income Applicable To Common Shares | 453,749 | 185,674 | 218,563 | 201,275 |